Principles of blood irradiation, dose validation, and quality control

Transfusion

Volumn 37, Issue 10, 1997, Pages 1084-1092

  Moroff, G ^a   Leitman, S F ^b   Luban, N L C ^c  

^a HOLLAND LABORATORY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CESIUM 137;

BLOOD COMPONENT THERAPY; CRYOPRESERVATION; GRAFT VERSUS HOST REACTION; MIXED LYMPHOCYTE CULTURE; PHOTON; PRACTICE GUIDELINE; QUALITY CONTROL; RADIATION DOSE; REVIEW; ULTRAVIOLET IRRADIATION;

EID: 0030777821     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1997.371098016450.x     Document Type: Review

References (27)

1. Moroff G, Luban NLC. Prevention of transfusion-associated graft-versus-host disease (editorial). Transfusion 1992;32:102-3.
2. Linden JV, Pisciotto PT. Transfusion-associated graft-versus-host disease and blood irradiation. Transfus Med Rev 1992;6:116-23.
3. Leitman SF. Dose, dosimetry, and quality improvement of irradiated blood components (editorial). Transfusion 1993;33:447-9.
4. Hall EJ. Radiobiology for the radiologist. 3rd ed. Philadelphia: Lippincott, 1988:3-12.
5. Deeg HJ. Ultraviolet irradiation in transplantation biology. Manipulation of immunity and immunogenicity. Transplantation 1988;45:845-51.
6. Capon SM, Sacher RA, Deeg HJ. Effective ultraviolet irradiation of platelet concentrates in teflon bags. Transfusion 1990;30:678-81.
7. Drobyski W, Thibodeau S, Truitt RL, et al. Third-party-mediated graft rejection and graft-versus-host disease after T-cell-depleted bone marrow transplantation, as demonstrated by hypervariable DNA probes and HLA-DR polymorphism. Blood 1989;74:2285-94.
8. Lowenthal RM, Challis DR, Griffiths AE, et al. Transfusion-associated graft-versus-host disease: report of an occurrence following the administration of irradiated blood. Transfusion 1993;33:524-9.
9. Sproul AM, Chalmers EA, Mills KI, et al. Third party mediated graft rejection despite irradiation of blood products. Br J Haematol 1992;80:251-2.
10. Pelszynski MM, Moroff G, Luban NL, et al. Effect of gamma irradiation of red blood cell units on T-cell inactivation as assessed by limiting dilution analysis: implications for preventing transfusion-associated graft-versus-host disease. Blood 1994;83:1683-9.
11. Center for Biologics Evaluation and Research. License amendments and procedures for gamma irradiation of blood products. Bethesda, MD: Food and Drug Administration, July 22, 1993.
12. Luban NLC, Drothler D, Moroff G, Quinones R. The effect of irradiation on lymphocyte reactivity in plateletpheresis components assessed by limiting dilution analysis (abstract). Transfusion 1994;34(Suppl):66S.
13. Rosen NR, Weidner IG, Boldt HD, Rosen DS. Prevention of transfusion-associated graft-versus-host disease: selection of an adequate dose of gamma radiation. Transfusion 1993;33:125-7.
14. Davey RJ, McCoy NC, Yu M, et al. The effect of prestorage irradiation on posttransfusion red cell survival. Transfusion 1992;32:525-8.
15. Read EJ, Kodis C, Carter CS, Leitman SF. Viability of platelets following storage in the irradiated state. A pair-controlled study. Transfusion 1988;28:446-50.
16. Suda BA, Leitman SF, Davey RJ. Characteristics of red cells irradiated and subsequently frozen for long-term storage. Transfusion 1993;33:389-92.
17. Fearon TC, Luban NLC. Practical dosimetric aspects of blood and blood product irradiation. Transfusion 1986;26:457-9.
18. Perkins JT, Papoulias SA. The effect of loading conditions on dose distribution within a blood irradiator (abstract). Transfusion 1994;34(Suppl):75S.
19. Luban NLC, Fearon T, Leitman SF, Moroff G. Absorption of gamma radiation in simulated blood components using cesium (Cs) irradiators (abstract). Transfusion 1995;35(Suppl):63S.
20. Masterson ME, Febo R. Pretransfusion blood irradiation: clinical rationale and dosimetric considerations. Med Phys 1992;19:649-57.
21. Report of validation for irradiation dosimetry of model IBL 437C blood product irradiator. Bedford, MA: CIS-US, Inc. 1993.
22. McLaughlin WL, Boyd AW, Chadwick KH, et al. Dosimetry for radiation processing. London: Taylor and Francis, 1989.
23. Chu RD, Van Dyk G, Lewis DF, et al. GafChromic dosimetry media: a new high dose, thin film routine dosimeter and dose mapping tool. Radiat Phys Chem 1990;35:767-73.
24. Leitman SF. Leukocyte inactivation by blood irradiation. In: Rossi EC, Simon TL, Moss GS, Gould SA, eds. Principles of transfusion medicine. 2nd ed. Baltimore: Williams & Wilkins, 1995:375-82.
25. Kutcher GJ, Coia L, Gillin M, et al. Comprehensive QA for radiation oncology: report of AAPM Radiation Therapy Committee Task Group 40. Med Phys 1994;21:581-618.
26. Nath R, Biggs PJ, Bova FJ, et al. AAPM code of practice for radiotherapy accelerators: report of AAPM Radiation Therapy Task Group No. 45. Med Phys 1994;21:1093-121.
27. Leitman SF, Silberstein L, Fairman RM, Lewis DF. Use of a radiation-sensitive film label in the quality control of irradiated blood components (abstract). Transfusion 1992;32(Suppl):4S.